Bimekizumab

• A study to learn more about the amount of bimekizumab in the breast milk of women with chronic inflammatory conditions who are breastfeeding Pending
  2024-518689-29-00 Phase I (Other) 2 countries UCB Biopharma
• Evaluation of the efficacy and safety of bimekizumab (BZK) or adalimumab (ADA) in the treatment of anterior chest wall pain associated with … Pending
  2025-520632-42-00 Phase III 1 country Centre Hospitalier Universitaire Rouen
• A study to learn how safe bimekizumab is and how well it works in adults with palmoplantar pustulosis Recruiting
  2024-520337-80-00 Phase III 8 countries UCB Biopharma
• A study to learn how the study drug bimekizumab works and how safe it is in treating moderate to severe hidradenitis suppurativa in children… Recruiting
  2023-505323-31-00 Phase III 2 countries UCB Biopharma
• Early intervention in plaque psoriasis: is bimekizumab able to delay chronic inflammation? Prospective multicenter interventional study Recruiting
  2024-514647-29-01 Phase II 1 country Centre Hospitalier Universitaire De Nice
• A study to learn if bimekizumab is safe and how it moves throughout the body in children with certain types of juvenile idiopathic arthritis Recruiting
  2023-508845-41-00 Phase III 4 countries UCB Biopharma
• A study to learn how bimekizumab works in children and teenagers with moderate to severe plaque psoriasis Recruiting
  2023-503859-10-00 Phase III 8 countries UCB Biopharma
• A study to learn how well bimekizumab works and how safe it is in adults with psoriatic arthritis Ended
  2024-511738-11-00 Phase III 6 countries UCB Biopharma
• A study to learn how bimekizumab works in people with moderate to severe plaque psoriasis. Ended
  2023-506333-29-00 Phase III/IV 2 countries UCB Biopharma
• A study to learn how safe bimekizumab, how well it works and how it moves through the bloodstream in adolescents with moderate to severe pla… Ended
  2023-509832-24-00 Phase II 2 countries UCB Biopharma
• An extension study to learn if Bimekizumab is safe and works as a long-term therapy in adults with moderate to severe hidradenitis suppurati… Ended
  2024-511035-10-00 Phase III 9 countries UCB Biopharma
• An extension study to learn if Bimekizumab works and is safe over a long period in adults with Active Axial Spondyloarthritis. Ended
  2023-506527-28-00 Phase III 7 countries UCB Biopharma
• A study to learn if Bimekizumab is safe and works over a long period in adults with Active Psoriatic Arthritis Ended
  2023-506528-95-00 Phase III 8 countries UCB Biopharma

Showing 1–13 of 13 trials